Therapies

Product Pipeline

Ritter Pharmaceuticals’ focus is on microbiome modifiers that change and enhance the microbial populations in the gastrointestinal tract in order to improve the health of individuals suffering from a variety of metabolic, gastrointestinal, and inflammatory diseases. Microbiome modifiers, or prebiotics, are dietary based gut microbiota management tools that improve health by fortifying beneficial bacteria indigenous to the digestive tract. This technology has expansive promise for the development of numerous products that will treat a variety of conditions and improve digestive health.

Featuring Recent Posts WordPress Widget development by YD